GMAB FY 2020 Earnings Report — Genmab A/S Revenue & Financial Results | Market Cap Arena

FY 2020 Earnings

Reported March 29, 2021

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2020	Prior Q	FY 2019	QoQ Change	YoY Change
Revenue	$1.6B	—	—	—	—
Op. Income	$989M	—	—	—	—
Gross Margin	100.0%	—	—	—	—
Net Margin	47.1%	—	—	—	—
EPS (Diluted)	$1.13	—	—	—	—
Free Cash Flow	$960M	—	—	—	—

Revenue Flow

Item	Amount
REVENUE	$1.6B
Cost of Revenue	$0
GROSS PROFIT	$1.6B
R&D Expenses	$491M
Selling & Marketing	$0
General & Administrative	$104M
SG&A Expenses	$104M
Other Expenses	$0
Operating Expenses	$595M
Cost & Expenses	$595M
OPERATING INCOME	$989M
Interest Income	$29M
Interest Expense	$2M
Other Income/Expenses	-$64M
INCOME BEFORE TAX	$925M
Income Tax Expense	$180M
Net Income from Continuing Ops	$745M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$745M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$745M
D&A	$39M
EBIT	$927M
EBITDA	$965M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$1.6B
Cost of Revenue	$0
GROSS PROFIT	$1.6B
R&D Expenses	$491M
Selling & Marketing	$0
General & Administrative	$104M
SG&A Expenses	$104M
Other Expenses	$0
Operating Expenses	$595M
Cost & Expenses	$595M
OPERATING INCOME	$989M
Interest Income	$29M
Interest Expense	$2M
Other Income/Expenses	-$64M
INCOME BEFORE TAX	$925M
Income Tax Expense	$180M
Net Income from Continuing Ops	$745M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$745M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$745M
D&A	$39M
EBIT	$927M
EBITDA	$965M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$745M
Depreciation & Amortization	$42M
Stock-Based Compensation	$31M
Deferred Income Tax	$0
Other Non-Cash Items	$141M
Change in Working Capital	$48M
OPERATING CASH FLOW	$1.0B
Capital Expenditure	-$48M
Acquisitions (Net)	$0
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	-$320M
NET CASH FROM INVESTING	-$368M
Net Debt Issuance	-$7M
Common Stock Repurchased	-$4M
Common Dividends Paid	$0
Other Financing Activities	$22M
NET CASH FROM FINANCING	$11M
FREE CASH FLOW	$960M
Net Change in Cash	$581M

Balance Sheet

Item	Amount
Cash & Equivalents	$1.1B
Short-Term Investments	$1.4B
Net Receivables	$386M
Inventory	$0
Other Current Assets	$39M
TOTAL CURRENT ASSETS	$2.9B
PP&E (Net)	$115M
Goodwill	$0
Intangible Assets	$53M
Long-Term Investments	$169M
Tax Assets	$0
Other Non-Current Assets	$31M
TOTAL NON-CURRENT ASSETS	$368M
TOTAL ASSETS	$3.3B
Account Payables	$0
Short-Term Debt	$0
Deferred Revenue	$0
Other Current Liabilities	$190M
TOTAL CURRENT LIABILITIES	$196M
Long-Term Debt	$0
Deferred Revenue NC	$0
Deferred Tax Liabilities	$0
Other Non-Current Liabilities	$77M
TOTAL NON-CURRENT LIABILITIES	$120M
TOTAL LIABILITIES	$317M
Common Stock	$10M
Additional Paid-In Capital	$1.9B
Retained Earnings	$1.1B
Treasury Stock	$0
Accum. Other Comp. Income	$8M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$3.0B
Minority Interest	$0
TOTAL EQUITY	$3.0B
TOTAL LIABILITIES & EQUITY	$3.3B
Total Debt	$50M
Net Debt	-$1.1B